Short-duration psychedelic therapy shows promise for major depression treatment
The Future of Depression Treatment: Could Short-Acting Psychedelics Be a Game Changer? A recent phase IIa clinical trial published in Nature Medicine is generating excitement in the field of mental health. The study explored the potential of dimethyltryptamine (DMT), a short-acting psychedelic, as a rapid treatment for major depressive disorder (MDD). While still early days, … Read more